Drugs / ACCS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02071199 | Mar 2014 → Oct 2015 | gingivitis | Noveome Biotherapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACCS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02071199 ↗ |
| Known as | Amnion-derived Cellular Cytokine Solution | “1X ACCS (Amnion-derived Cellular Cytokine Solution)” NCT02071199 ↗ |
| Route | Topical | “It will be given topically intra-orally daily Monday through Friday for 2 weeks” NCT02071199 ↗ |